Share this @internewscast.com

A revolutionary new treatment for type 1 diabetes could be on the horizon, which involves growing insulin-producing cells in a lab and transplanting them into a patient’s arm.

Currently those with the condition – of which there are around 400,000 in the UK – have to regularly monitor blood sugar levels and inject insulin when needed.

But researchers believe a new procedure could free patients from the need to constantly manage their condition.

Their lab-grown ‘islet’ cells are designed to sit just below the skin and allow the arm to take on the role of the pancreas – the organ that usually produces insulin but which fails to work properly in type 1 diabetes.

A clinical trial is currently underway which involves islet cells from human donors being transplanted into the forearms of eight people with the condition.

Those with the type  diabetes ¿ of which there are around 400,000 in the UK ¿ have to regularly monitor blood sugar levels and inject insulin when needed, but this new technology could change that

Those with the type  diabetes – of which there are around 400,000 in the UK – have to regularly monitor blood sugar levels and inject insulin when needed, but this new technology could change that

In the last few decades a small number of people have had donated insulin-producing cells injected into the portal vein, which takes them to the liver.

But there are supply issues and the new technique – described by experts as a ‘potential gamechanger’ – would be much less invasive.

However, much larger-scale testing would be needed before it could be rolled out.

It is being developed by Minutia, a biotech company that is working with technology developed at the University of California, San Francisco and Duke University.

The long-term aim is to be able to take stem cells, which have the potential to turn into almost any other kind of cell, and to coax them into becoming insulin-producing ‘islets’ which could be transplanted into the arm.

The company is also developing a type of ‘nanosensor’ that goes inside the transplanted cells, which could give an early warning if the transplant is being rejected by a recipient.

Katy Digovich, chief executive and co-founder of Minutia, said: ‘We know it is possible now to reverse type 1 diabetes with stem cell-derived insulin-producing cells, and we also know that we can transplant insulin-producing cells into the forearm and have them survive.

‘We’re going to do everything in our power to make it work. But this is hard.’

Dr Digovich was diagnosed with type 1 diabetes at the age of six, but her decision to research the condition came after she spent time in Africa with the Clinton Health Access Initiative.

During her time there people were often surprised to learn that she – a nearly 6-foot-tall, athletic former college basketball player — was living with type 1 diabetes, a diagnosis in many countries in Africa that often translates into stunted growth, amputations and high mortality.

‘Ultimately, I got really angry and the switch flipped,’ she said. ‘If I was born there, I would be dead. That really hit close to home.

‘I took stock of my career and threw myself into the diabetes space trying to create the type of transplant I want in my own body.’

Dr Matthias Hebrok, from the Technical University Munich and co-founder of Minutia, said that transplanting islets from the pancreas of a deceased person is an established treatment that works well – but there is a chronic shortage of donors.

‘I think the stem cell-derived cells are a revolution,’ he said. ‘Of course, we’re at the very early stages … but we could generate as many cells as we would like, to treat a tremendous number of patients.’

The work was presented at the American Association for the Advancement of Science (AAAS) conference, held in Denver this week.

Share this @internewscast.com
You May Also Like

Your Brain’s Shape May Help Forecast Future Dementia Risk

Scientists have determined that how the brain shape changes with age could…

Dr. Mosley’s Latest Fast 800 Diet: Turbocharge Weight Loss with Ozempic or Mounjaro—Achieve Results in 12 Weeks, Jabs Optional!

The sudden surge in the cost of weight-loss injections has forced thousands…

Debate arises over doctor’s easy sleep hack using a common closet item

There’s nothing more frustrating than lying awake in bed, staring at the…

I’m a Pharmacist: Many People Unknowingly Make a Big Mistake with Their Underwear Choices

Most people don’t often consider it, but your underwear drawer might be…

Trish Tragically Passed Away After Enduring Years of Pain from Commonly Prescribed Antibiotics. Her Heartbroken Daughter Issues a Somber Warning to Others

Just hours before her passing, a revelation stunned many of Trish Lightwood’s…

Doctors Dismissed My Swollen Moon Face as Normal, But It Was Actually an Early Sign of a Hidden Tumor

When new mother Katelyn Bonacasa noticed a bumpy red rash shortly after…

Told I Have a Year to Live, I’m Donating My Tears to Help Combat Cancer

A selfless dad-of-two battling an incurable tumour has donated his tears to…

Minor Throat Alteration: A Potential Indicator of New Covid Variant Stratus

If you’re feeling unwell with a sharp sore throat and high fever,…

Could You Be a Functioning Alcoholic? Six Warning Signs You Might Have a Problem, According to Dr. Max Pemberton

For quite some time, I couldn’t stand the idea of Sober October,…

Rapid Health Assessment: Faster Than Brewing a Cup of Tea

Breast cancer remains the most prevalent type of cancer among women globally,…